Back to ABBV

AbbVie Inc. Short-Term Debt 2012-2026 | ABBV

Beta

What is short-term debt?

Short-term debt includes borrowings and the current portion of long-term debt due within one year.

What is AbbVie Inc.'s current short-term debt?

AbbVie Inc. (ABBV) annual short-term debt for 2025 was $2.50B, a Infinity% increase from 2024. AbbVie Inc. short-term debt for the quarter ending March 31, 2026 was $0.

What was AbbVie Inc.'s short-term debt in 2024?

AbbVie Inc. annual short-term debt for 2024 was $0, a NaN% decline from 2023.

What was AbbVie Inc.'s short-term debt in 2023?

AbbVie Inc. annual short-term debt for 2023 was $0, a 100.00% decline from 2022.

What is AbbVie Inc.'s 5-year short-term debt CAGR?

AbbVie Inc. short-term debt grew at a compound annual growth rate (CAGR) of 136.19% from FY2020 to FY2025, going from $34.0M to $2.50B over 5 years.

Short-Term Debt History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+136.2%
FY2020
$34.0M
FY2025
$2.50B
1213141516171819202122232425
5 years selected
Short-Term Debt History
PeriodValueChangeSource
FY2025$2.50B-10-K
FY2024$0-10-K
FY2023$0-100.0%10-K
FY2022$1.0M-92.9%10-K
FY2021$14.0M-58.8%10-K
FY2020$34.0M-10-K
FY2019$0-100.0%10-K
FY2018$3.70B+824.8%10-K
FY2017$400.0M+6.1%10-K
FY2016$377.0M-7.1%10-K
FY2015$406.0M-4.5%10-K
FY2014$425.0M+2.9%10-K
FY2013$413.0M-59.5%10-K
FY2012$1.02B-10-K
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →